Loyal is a biotechnology company developing medicines to extend dog lifespan.
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 23, 2021 | Series A | $27M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Predictive VC | — | Series A |